MX2024013203A - Composiciones farmaceuticas y nutraceuticas con una combinacion de aminoacidos y su uso en enfermedades caracterizadas por la acumulacion de lipidos en los tejidos. - Google Patents
Composiciones farmaceuticas y nutraceuticas con una combinacion de aminoacidos y su uso en enfermedades caracterizadas por la acumulacion de lipidos en los tejidos.Info
- Publication number
- MX2024013203A MX2024013203A MX2024013203A MX2024013203A MX2024013203A MX 2024013203 A MX2024013203 A MX 2024013203A MX 2024013203 A MX2024013203 A MX 2024013203A MX 2024013203 A MX2024013203 A MX 2024013203A MX 2024013203 A MX2024013203 A MX 2024013203A
- Authority
- MX
- Mexico
- Prior art keywords
- tissues
- pharmaceutical
- diseases characterized
- combination
- amino acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22382390 | 2022-04-25 | ||
| PCT/EP2023/060827 WO2023208944A1 (en) | 2022-04-25 | 2023-04-25 | Pharmaceutical and nutraceutical compositions with a combination of amino acids and its use in diseases characterized by lipid accumulation in tissues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024013203A true MX2024013203A (es) | 2025-02-10 |
Family
ID=81579974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024013203A MX2024013203A (es) | 2022-04-25 | 2024-10-25 | Composiciones farmaceuticas y nutraceuticas con una combinacion de aminoacidos y su uso en enfermedades caracterizadas por la acumulacion de lipidos en los tejidos. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250268855A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4514147A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025515358A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119343061A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3249636A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024013203A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023208944A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) * | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| US11246846B2 (en) * | 2017-10-23 | 2022-02-15 | Michael S. Tempesta | Trisodium citrate compositions having enhanced uptake across digestive mucosa |
-
2023
- 2023-04-25 US US18/859,892 patent/US20250268855A1/en active Pending
- 2023-04-25 CA CA3249636A patent/CA3249636A1/en active Pending
- 2023-04-25 WO PCT/EP2023/060827 patent/WO2023208944A1/en not_active Ceased
- 2023-04-25 EP EP23722509.9A patent/EP4514147A1/en active Pending
- 2023-04-25 JP JP2024563636A patent/JP2025515358A/ja active Pending
- 2023-04-25 CN CN202380049301.0A patent/CN119343061A/zh active Pending
-
2024
- 2024-10-25 MX MX2024013203A patent/MX2024013203A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4514147A1 (en) | 2025-03-05 |
| CN119343061A (zh) | 2025-01-21 |
| CA3249636A1 (en) | 2023-11-02 |
| JP2025515358A (ja) | 2025-05-14 |
| WO2023208944A1 (en) | 2023-11-02 |
| US20250268855A1 (en) | 2025-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nirmal et al. | Valorization of fish byproducts: sources to end‐product applications of bioactive protein hydrolysate | |
| JP7104018B2 (ja) | コラーゲンペプチド含有組成物の苦味マスキング方法 | |
| CN112399799A (zh) | 脂肪蓄积抑制用组合物 | |
| MY177974A (en) | A pharmaceutical composition for prevention of diet induced obesity | |
| JP6222663B2 (ja) | 筋委縮抑制剤 | |
| Jeelani et al. | The therapeutic potential of chia seeds as medicinal food: A review | |
| JP2009159983A (ja) | 食品組成物 | |
| CA2521967A1 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
| JP2014504261A5 (cg-RX-API-DMAC7.html) | ||
| ES2544894T3 (es) | Hidrolizados de proteínas animales de origen marino con propiedades neuroprotectoras | |
| JP2006304792A (ja) | 内臓脂肪蓄積抑制食品 | |
| JP7188936B2 (ja) | 抗炎症剤 | |
| JP6393501B2 (ja) | 多価不飽和脂肪酸含有油脂の風味改善剤 | |
| WO2006109194A3 (en) | Chromium-fatty acid compounds and methods of making and using thereof | |
| WO2011145307A1 (ja) | アディポネクチン産生促進組成物 | |
| JP2010270030A (ja) | 抗菌ペプチドの発現誘導剤または分泌促進剤 | |
| JP6901597B2 (ja) | アスタキサンチン含有組成物 | |
| JP2014210792A (ja) | 経口組成物 | |
| JP6483244B2 (ja) | 蜂の子を含有する滋養強壮剤 | |
| MX2022010949A (es) | Composiciones de avenantramida con solubilidad mejorada que comprenden 4-hidroxifenona. | |
| JP6514500B2 (ja) | 関節痛及び腰痛改善剤 | |
| MX2019015712A (es) | Formas cristalinas de beta-sitosterol. | |
| JP2014224074A (ja) | ヤナギ科ヤナギ属植物の抽出物を含有するエラスターゼ活性抑制剤 | |
| WO2019232493A1 (en) | Hempseed oil compositions | |
| RU2402942C1 (ru) | Биологически активная добавка к пище, обладающая гепатопротекторными свойствами |